JP2019512465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019512465A5 JP2019512465A5 JP2018544186A JP2018544186A JP2019512465A5 JP 2019512465 A5 JP2019512465 A5 JP 2019512465A5 JP 2018544186 A JP2018544186 A JP 2018544186A JP 2018544186 A JP2018544186 A JP 2018544186A JP 2019512465 A5 JP2019512465 A5 JP 2019512465A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- alkyl
- substituted
- compound according
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662297450P | 2016-02-19 | 2016-02-19 | |
| US62/297,450 | 2016-02-19 | ||
| PCT/US2017/018511 WO2017143291A1 (en) | 2016-02-19 | 2017-02-17 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019512465A JP2019512465A (ja) | 2019-05-16 |
| JP2019512465A5 true JP2019512465A5 (enExample) | 2020-03-26 |
| JP6956098B2 JP6956098B2 (ja) | 2021-10-27 |
Family
ID=59625486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544186A Active JP6956098B2 (ja) | 2016-02-19 | 2017-02-17 | 変異体ｐ５３機能を復元させるための方法および化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10138219B2 (enExample) |
| EP (1) | EP3416638A4 (enExample) |
| JP (1) | JP6956098B2 (enExample) |
| KR (1) | KR102868217B1 (enExample) |
| CN (2) | CN119161324B (enExample) |
| AU (1) | AU2017221472B2 (enExample) |
| CA (2) | CA3215564C (enExample) |
| IL (2) | IL286839B (enExample) |
| MX (1) | MX383904B (enExample) |
| WO (1) | WO2017143291A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL286839B (en) | 2016-02-19 | 2022-08-01 | Pmv Pharmaceuticals Inc | Propyne-indole compounds |
| SMT202500339T1 (it) | 2019-09-23 | 2025-11-10 | Pmv Pharmaceuticals Inc | Metodi e composti per ripristinare la funzione di p53 mutante |
| US11807644B2 (en) | 2020-05-12 | 2023-11-07 | Pmv Pharmaceuticals, Inc. | Methods and compounds for restoring mutant p53 function |
| CN111686127B (zh) * | 2020-06-04 | 2022-02-15 | 华南理工大学 | 锌铁纳米材料在降解突变p53蛋白中的应用 |
| CN113750246B (zh) * | 2020-06-04 | 2023-12-05 | 华南理工大学 | ZIF-8纳米材料在降解广谱突变p53蛋白中的应用 |
| US11731953B2 (en) * | 2020-06-22 | 2023-08-22 | Pmv Pharmaceuticals, Inc. | Methods and compounds for restoring mutant p53 function |
| US12570645B2 (en) * | 2020-06-22 | 2026-03-10 | Pmv Pharmaceuticals, Inc. | Uses of p53 x-ray co-crystal structures |
| US11926632B2 (en) * | 2020-06-22 | 2024-03-12 | Pmv Pharmaceuticals, Inc. | Methods and compounds for restoring mutant p53 function |
| US20230049952A1 (en) * | 2020-06-24 | 2023-02-16 | Pmv Pharmaceuticals, Inc. | Methods and compounds for restoring mutant p53 function |
| CA3183025A1 (en) * | 2020-06-24 | 2021-12-30 | Melissa Dumble | Companion diagnostic tool for mutant p53 reactivating compounds |
| WO2021262484A1 (en) * | 2020-06-24 | 2021-12-30 | Pmv Pharmaceuticals, Inc. | Combination therapy for treatment of cancer |
| EP4267553A1 (en) | 2020-12-24 | 2023-11-01 | Escient Pharmaceuticals, Inc. | Modulators of mas-related g-protein receptor x2 and related products and methods |
| WO2022213975A1 (en) * | 2021-04-08 | 2022-10-13 | Jacobio Pharmaceuticals Co., Ltd. | Compounds targeting y220c mutant of p53 |
| UY39890A (es) * | 2021-08-10 | 2023-03-31 | Jacobio Pharmaceuticals Co Ltd | Compuestos con diana en mutante de p53 |
| CN117916230A (zh) * | 2021-08-27 | 2024-04-19 | 杭州紫晶医药科技有限公司 | 作为p53调节剂的化合物 |
| AU2023213949A1 (en) | 2022-01-27 | 2024-07-25 | Pmv Pharmaceuticals, Inc. | Deuterated compounds for restoring mutant p53 function |
| CN119585275A (zh) * | 2022-07-22 | 2025-03-07 | 深圳众格生物科技有限公司 | 恢复p53突变功能的化合物及其应用 |
| CN119968361A (zh) * | 2022-08-22 | 2025-05-09 | 北京加科思新药研发有限公司 | 靶向p53 Y220突变体的化合物 |
| WO2024083223A1 (zh) * | 2022-10-21 | 2024-04-25 | 正大天晴药业集团股份有限公司 | 大环类化合物及其医药用途 |
| CN120265637A (zh) * | 2022-12-08 | 2025-07-04 | 北京加科思新药研发有限公司 | 靶向p53突变体的化合物 |
| CN121693500A (zh) * | 2023-08-09 | 2026-03-17 | 德睿智药(苏州)新药研发有限公司 | 用于调节p53功能的新型杂环类化合物 |
| WO2025011684A2 (zh) * | 2023-10-20 | 2025-01-16 | 上海宇道生物技术有限公司 | 一类n-磺酰酰胺含氮稠杂环类化合物及其应用 |
| WO2025242903A1 (en) * | 2024-05-24 | 2025-11-27 | Onco3R Therapeutics Bv | Compounds and pharmaceutical compositions thereof for the treatment of proliferative diseases |
| WO2026025042A1 (en) * | 2024-07-26 | 2026-01-29 | Dana-Farber Cancer Institute, Inc. | P53 targeting compounds and uses thereof |
| WO2026067649A1 (zh) * | 2024-09-27 | 2026-04-02 | 奇树医药公司 | 恢复p53突变功能的化合物及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20010414A2 (en) * | 1998-12-02 | 2002-06-30 | Pfizer Prod Inc | METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| US6770652B2 (en) * | 2001-10-18 | 2004-08-03 | Duquesne University Of The Holy Ghost | Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| JP2007512263A (ja) * | 2003-11-25 | 2007-05-17 | ノボ ノルディスク アクティーゼルスカブ | 化学的脱共役剤として使用するためのインドール誘導体 |
| WO2006014482A1 (en) | 2004-07-08 | 2006-02-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pyrimidine derivatives useful as inhibitors of pkc-theta |
| WO2006136823A1 (en) | 2005-06-21 | 2006-12-28 | Astex Therapeutics Limited | Heterocyclic containing amines as kinase b inhibitors |
| US8822420B2 (en) * | 2008-03-13 | 2014-09-02 | Universita Degli Studi Di Trieste | Peptides and aptamers thereof as specific modulators of mutant p53 function |
| US8367665B2 (en) * | 2008-04-16 | 2013-02-05 | Karo Bio Ab | Estrogen receptor ligands |
| GB0808282D0 (en) * | 2008-05-07 | 2008-06-11 | Medical Res Council | Compounds for use in stabilizing p53 mutants |
| CN102427729B (zh) * | 2009-03-27 | 2014-09-03 | 默沙东公司 | 丙型肝炎病毒复制的抑制剂 |
| DE102010049877A1 (de) | 2010-11-01 | 2012-05-03 | Merck Patent Gmbh | 7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate |
| ES2618812T3 (es) | 2011-01-20 | 2017-06-22 | Merck Sharp & Dohme Corp. | Antagonistas del receptor mineralocorticoide |
| GB201110390D0 (en) * | 2011-06-20 | 2011-08-03 | Medical Res Council | Compounds for use in stabilising p53 mutants |
| US9517252B2 (en) * | 2011-09-09 | 2016-12-13 | Agency For Science, Technology And Research | p53 activating peptides |
| EP2809656A2 (en) | 2011-12-28 | 2014-12-10 | Allergan, Inc. | Benzimidazole derivatives as selective blockers of persistent sodium current |
| US8822689B2 (en) | 2012-09-19 | 2014-09-02 | Merial Limited | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
| WO2015178955A1 (en) * | 2014-05-19 | 2015-11-26 | Eternity Bioscience Inc. | Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors |
| WO2016004513A1 (en) | 2014-07-11 | 2016-01-14 | Simon Fraser University | Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods |
| CN104672241B (zh) * | 2015-01-29 | 2018-04-24 | 王磊 | 吡咯并[2,3-d]嘧啶类化合物及其用途 |
| IL286839B (en) | 2016-02-19 | 2022-08-01 | Pmv Pharmaceuticals Inc | Propyne-indole compounds |
-
2017
- 2017-02-17 IL IL286839A patent/IL286839B/en unknown
- 2017-02-17 KR KR1020187026965A patent/KR102868217B1/ko active Active
- 2017-02-17 CA CA3215564A patent/CA3215564C/en active Active
- 2017-02-17 CN CN202411302298.1A patent/CN119161324B/zh active Active
- 2017-02-17 JP JP2018544186A patent/JP6956098B2/ja active Active
- 2017-02-17 AU AU2017221472A patent/AU2017221472B2/en active Active
- 2017-02-17 EP EP17753995.4A patent/EP3416638A4/en not_active Withdrawn
- 2017-02-17 WO PCT/US2017/018511 patent/WO2017143291A1/en not_active Ceased
- 2017-02-17 CA CA3010847A patent/CA3010847C/en active Active
- 2017-02-17 MX MX2018009947A patent/MX383904B/es unknown
- 2017-02-17 CN CN201780013450.6A patent/CN109069481A/zh active Pending
- 2017-02-17 US US15/436,333 patent/US10138219B2/en active Active
-
2018
- 2018-08-15 IL IL261175A patent/IL261175B/en unknown
- 2018-10-18 US US16/163,829 patent/US10640485B2/en active Active
-
2020
- 2020-03-16 US US16/819,934 patent/US11339141B2/en active Active
-
2022
- 2022-02-24 US US17/679,568 patent/US20220213062A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023203112B2 (en) | Peptide oligonucleotide conjugates | |
| JP2009530424A5 (enExample) | ||
| Ranjan et al. | Recognition of HIV-TAR RNA using neomycin–benzimidazole conjugates | |
| Luu et al. | A potent inhibitor of protein sequestration by expanded triplet (CUG) repeats that shows phenotypic improvements in a Drosophila model of myotonic dystrophy | |
| Cortez et al. | Incorporation of phosphonate into benzonaphthyridine toll-like receptor 7 agonists for adsorption to aluminum hydroxide | |
| JP2020513036A5 (enExample) | ||
| US11912999B2 (en) | Aptamer conjugates with N-heterocyclic carbene metal complexes for targeted drug delivery | |
| Huang et al. | Platinum (II) complexes containing aminophosphonate esters: Synthesis, characterization, cytotoxicity and action mechanism | |
| US7872027B2 (en) | Low molecular weight Myc-max inhibitors | |
| JP2013518036A5 (enExample) | ||
| AU2014235957A1 (en) | Fluorescent-HAP: a diagnostic stain for HBV cores in cells | |
| US10894035B2 (en) | Use of indole compounds to stimulate the immune system | |
| JP2024522183A (ja) | 非標準ｇ四重鎖構造に結合する化合物ならびにそれを作製および使用する方法 | |
| US9932333B2 (en) | Benzothiazole compound and medicine containing same | |
| Booijink et al. | A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis | |
| JP2024123209A (ja) | 腫瘍学及びウイルス学におけるハロゲン化キサンテンの新規の使用 | |
| ES2907624T3 (es) | Inhibidores de oxadiazol de HIPK2 para el tratamiento de la fibrosis renal | |
| WO2016172191A1 (en) | Compounds, compositions and methods for inhibiting cnksr1 | |
| US12544421B2 (en) | VDAC inhibitors for treating inflammatory bowel diseases | |
| CN107540624B (zh) | 热休克蛋白抑制剂及其制备方法和应用 | |
| CA2531869A1 (en) | Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna | |
| CN114907337B (zh) | 靶向cdk4或cdk6的共价抑制剂及其应用 | |
| RU2642426C1 (ru) | 1-Этил-6-фтор-4-оксо-7-(8-этокси-2-оксо-2Н-хромен-3-ил)-1,4-дигидрохинолин-3-карбоновая кислота, обладающая противотуберкулезной активностью | |
| EP4622962A1 (en) | Small molecular weight chemical compound to antagonize eph-ephrin tetramerization and inhibit bidirectional signaling | |
| WO2018017853A1 (en) | Nontoxic compounds for the treatment and prevention of herpesvirus infections |